Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

More realistic model hopes to replace animal testing
Nottingham researchers work on improving model of drug uptake

New research at the University of Nottingham aims to develop a more realistic model of drug uptake, which could offer an alternative to animal testing.

Led by Dr Martin Garnett at the university's School of Pharmacy, the research team are looking to deliver an improved cell-based model for determining how easily drugs and nanoparticles enter the body through the gut.

The three-year project has been granted funding of £152,780 by the Dr Hadwen Trust, a research charity that promotes and funds the development of techniques to replace animal testing in biomedical research.

Dr Garnett says that cell models which study drug uptake across the gut already exist. Commenting on the current research, he explained: "This work builds on previous work funded by the Dr Hadwen Trust where we investigated a component called ‘basement membrane’ which is present in normal gut, but absent in the conventional cell model.

"We have shown that basement membrane is important for both the normal growth of epithelial cells and as a barrier to uptake of some molecules and nanoparticles. In our new work we will extend these findings to produce a more realistic model."

An important part of the new study will be demonstrating and validating the beneficial effects of the basement membrane to the model.

To help improve its accuracy, scientists will incorporate M cells into the new model, as these have been found to help transport some nanoparticles. In addition, researchers say that the mucus produced by some cells in the epithelium can affect how quickly drugs pass into the gut.

The older model, according to the research team, uses a porous artificial membrane, or substrate, which has been found to prevent the movement of some larger molecules and particles. In the new model this substrate will be replaced with an innovative new support made from woven nanofibres.

Scientists say the new model could potentially reduce the need for animal testing, both in the pharmaceutical industry, and for toxicology studies on nano particles.

Become a member or log in to add this story to your CPD history

Birmingham Dogs Home makes urgent appeal

News Story 1
 Birmingham Dogs Home has issued an urgent winter appeal as it faces more challenges over the Christmas period.

The rescue centre has seen a dramatic increase in dogs coming into its care, and is currently caring for over 200 dogs. With rising costs and dropping temperatures, the charity is calling for urgent support.

It costs the charity £6,000 per day to continue its work.

Fi Harrison, head of fundraising and communications, said: "It's heart-breaking for our team to see the conditions some dogs arrive in. We really are their last chance and hope of survival."

More information about the appeal can be found here

Click here for more...
News Shorts
Avian flu confirmed at premises in Cornwall

A case of highly pathogenic avian influenza H5N1 has been detected in commercial poultry at a premises near Rosudgeon, Cornwall.

All poultry on the infected site will be humanely culled, and a 3km protection zone and 10km surveillance zone have been put in place. Poultry and other captive birds in the 3km protection zone must be housed.

The case is the second avian flu case confirmed in commercial poultry this month. The H5N5 strain was detected in a premises near Hornsea, East Riding of Yorkshire, in early November. Before then, the disease had not been confirmed in captive birds in England since February.

The UK chief veterinary officer has urged bird keepers to remain alert and practise robust biosecurity.

A map of the disease control zones can be found here.